Cargando…
Therapeutical Administration of Peptide Pep19-2.5 and Ibuprofen Reduces Inflammation and Prevents Lethal Sepsis
Sepsis is still a major cause of death and many efforts have been made to improve the physical condition of sepsis patients and to reduce the high mortality rate associated with this disease. While achievements were implemented in the intensive care treatment, all attempts within the field of novel...
Autores principales: | Heinbockel, Lena, Marwitz, Sebastian, Barcena Varela, Sergio, Ferrer-Espada, Raquel, Reiling, Norbert, Goldmann, Torsten, Gutsmann, Thomas, Mier, Walter, Schürholz, Tobias, Drömann, Daniel, Brandenburg, Klaus, Martinez de Tejada, Guillermo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510266/ https://www.ncbi.nlm.nih.gov/pubmed/26197109 http://dx.doi.org/10.1371/journal.pone.0133291 |
Ejemplares similares
-
Inhibition of Lipopolysaccharide- and Lipoprotein-Induced Inflammation by Antitoxin Peptide Pep19-2.5
por: Heinbockel, Lena, et al.
Publicado: (2018) -
Coupling killing to neutralization: combined therapy with ceftriaxone/Pep19-2.5 counteracts sepsis in rabbits
por: Bárcena-Varela, Sergio, et al.
Publicado: (2017) -
Lipoproteins/peptides are sepsis-inducing toxins from bacteria that can be neutralized by synthetic anti-endotoxin peptides
por: de Tejada, Guillermo Martinez, et al.
Publicado: (2015) -
Anti-Infective and Anti-Inflammatory Mode of Action of Peptide 19-2.5
por: Heinbockel, Lena, et al.
Publicado: (2021) -
Toxicological and Safety Pharmacological Profiling of the Anti-Infective and Anti-Inflammatory Peptide Pep19-2.5
por: Möller, Clemens, et al.
Publicado: (2022)